Handbook of Biogeneric Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
-
- $109.99
-
- $109.99
Publisher Description
More than 20 billion dollars worth of biopharmaceuticals are scheduled to go off-patent by 2006. Given the strong political impetus and the development of technological tools that can answer the questions regulatory authorities may raise, it is inevitable that the FDA and EMEA will allow biogeneric or biosimilar products. Even with all the regulato
GENRE
Professional & Technical
RELEASED
2002
15 August
LANGUAGE
EN
English
LENGTH
584
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
19.9
MB